About Curatio JSC
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Celgene
2
Optinose US Inc.
2
Actelion
1
AiCuris Anti-infective Cures AG
1
Reistone Biopharma Company Limited
1
Clinical Trials at Curatio JSC
During the past decade, Curatio JSC conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 1 clinical trials were completed, i.e. on
average, 16.7% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Study of Ozanimod (RPC1063) in Relapsing Multiple Sclerosis (MS)
2014-12-03
2016-12-22
Completed
1,346
A Multi-Site, Open-Label Extension Trial of Oral RPC1063 in Relapsing Multiple Sclerosis
2015-10-16
2023-01-05
Completed
2,350
Trial on Efficacy and Safety of Pritelivir Tablets for Treatment of Acyclovir-resistant Mucocutaneous HSV (Herpes Simplex Virus) Infections in Immunocompromised Subjects
2017-05-08
2024-10-01
Recruiting
153
Long-term Extension to Study AC-058B301 to Investigate Safety, Tolerability and Disease Control of Ponesimod 20 mg in Patients With Relapsing Multiple Sclerosis
2017-07-05
2024-01-18
Active, not recruiting
877
Study Evaluating the Efficacy and Safety of Intranasal Administration of OPN-375 in Subjects With Chronic Rhinosinusitis With or Without the Presence of Nasal Polyps
2018-11-27
2022-01-19
Completed
332
Study Evaluating the Efficacy and Safety of Intranasal Administration of OPN-375 in Subjects With Chronic Rhinosinusitis Without the Presence of Nasal Polyps
2019-05-01
2022-04-27
Completed
210
A Phase 3 Study to Investigate the Efficacy and Safety of SHR0302 With Moderately to Severely Active Ulcerative Colitis
2021-11-05
2025-03-31
Recruiting
368
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Curatio JSC" #1 sponsor was "Celgene" with 2 trials, followed by "Optinose US Inc." with 2 trials
sponsored, "Actelion" with 1 trials sponsored, "AiCuris Anti-infective Cures AG" with 1 trials sponsored and "Reistone Biopharma Company Limited"
with 1 trials sponsored. Other sponsors include -5 different institutions and
companies that sponsored additional 5 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Curatio JSC"
#1 collaborator was "Medpace, Inc." with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at Curatio JSC
According to Clinical.Site data, the most researched conditions in "Curatio JSC" are
"Multiple Sclerosis" (3 trials), "Chronic Rhinosinusitis" (2 trials), "HSV Infection" (1 trials) and "Ulcerative Colitis" (1 trials). Many other conditions were trialed in "Curatio JSC" in a lesser frequency.
Clinical Trials Intervention Types at Curatio JSC
Most popular intervention types in "Curatio JSC" are "Drug" (7 trials). Other intervention types were less common.
The name of intervention was led by "OPN-375" (2 trials), "Foscarnet" (1 trials), "Interferon beta-1a" (1 trials), "Ozanimod" (1 trials) and "Placebo" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Curatio JSC
The vast majority of trials in "Curatio JSC" are
7 trials for "All" genders.
Clinical Trials Status at Curatio JSC
Currently, there are NaN active trials in "Curatio JSC".
undefined are not yet recruiting,
2 are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 4 completed trials in Curatio JSC,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Curatio JSC, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 7 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".